124 related articles for article (PubMed ID: 35404897)
21. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
22. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
23. Derivation and External Validation of Machine Learning-Based Model for Detection of Pancreatic Cancer.
Chen W; Zhou Y; Xie F; Butler RK; Jeon CY; Luong TQ; Zhou B; Lin YC; Lustigova E; Pisegna JR; Kim S; Wu BU
Am J Gastroenterol; 2023 Jan; 118(1):157-167. PubMed ID: 36227806
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.
Bagni K; Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Hansen CP; Preus Hasselby J; Holländer NH; Nissen M; Bjerregaard JK; Pfeiffer P; Yilmaz MK; Rasmussen LS; Nielsen SE; Johansen JS
Eur J Cancer Care (Engl); 2020 May; 29(3):e13219. PubMed ID: 31908093
[TBL] [Abstract][Full Text] [Related]
25. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data.
Jia K; Kundrot S; Palchuk MB; Warnick J; Haapala K; Kaplan ID; Rinard M; Appelbaum L
EBioMedicine; 2023 Dec; 98():104888. PubMed ID: 38007948
[TBL] [Abstract][Full Text] [Related]
26. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
[TBL] [Abstract][Full Text] [Related]
27. New-Onset Diabetes Is a Potential Marker for the Malignant Transformation of Pancreatic Cysts: A Real-World Population Cohort Study.
Schweber AB; Agarunov E; Brooks C; Hur C; Gonda TA
Pancreas; 2022 Oct; 51(9):1186-1193. PubMed ID: 37078944
[TBL] [Abstract][Full Text] [Related]
28. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population.
Brewer MJ; Doucette JT; Bar-Mashiah A; Glickman JW; Kessel E; Aronson A; Lucas AL
Clin Gastroenterol Hepatol; 2022 May; 20(5):1105-1111.e2. PubMed ID: 34358720
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma.
Chang MC; Chen CH; Liang JD; Tien YW; Hsu C; Wong JM; Chang YT
World J Gastroenterol; 2014 May; 20(17):5060-5. PubMed ID: 24803819
[TBL] [Abstract][Full Text] [Related]
30. Body mass index and pancreatic adenocarcinoma: A nationwide registry-based cohort study.
Saeed U; Myklebust TÅ; Robsahm TE; Møller B; Mala T; Skålhegg BS; Yaqub S
Scand J Surg; 2023 Mar; 112(1):11-21. PubMed ID: 36173093
[TBL] [Abstract][Full Text] [Related]
31. Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Coté GA; Xu H; Easler JJ; Imler TD; Teal E; Sherman S; Korc M
Am J Epidemiol; 2017 Oct; 186(8):944-951. PubMed ID: 28541521
[TBL] [Abstract][Full Text] [Related]
32. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
[TBL] [Abstract][Full Text] [Related]
33. Effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma mortality: A retrospective cohort study consisting of 1783 patients.
Zhang S; Wang C; Huang H; Jiang Q; Zhao D; Tian Y; Ma J; Yuan W; Sun Y; Che X; Zhang J; Chen H; Zhao Y; Chu Y; Zhang Y; Chen Y
Sci Rep; 2017 Aug; 7(1):9572. PubMed ID: 28851896
[TBL] [Abstract][Full Text] [Related]
34. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.
Balasenthil S; Huang Y; Liu S; Marsh T; Chen J; Stass SA; KuKuruga D; Brand R; Chen N; Frazier ML; Jack Lee J; Srivastava S; Sen S; McNeill Killary A
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376184
[TBL] [Abstract][Full Text] [Related]
35. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.
Andersen DK; Korc M; Petersen GM; Eibl G; Li D; Rickels MR; Chari ST; Abbruzzese JL
Diabetes; 2017 May; 66(5):1103-1110. PubMed ID: 28507210
[TBL] [Abstract][Full Text] [Related]
36. Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.
Chung KH; Lee JC; Lee J; Cho IK; Kim J; Jang W; Yoo BC; Hwang JH
Pancreatology; 2020 Oct; 20(7):1465-1471. PubMed ID: 32873483
[TBL] [Abstract][Full Text] [Related]
37. Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis.
Klatte DCF; Boekestijn B; Onnekink AM; Dekker FW; van der Geest LG; Wasser MNJM; Feshtali S; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME;
Gastroenterology; 2023 Jun; 164(7):1223-1231.e4. PubMed ID: 36889551
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic Adenocarcinoma Causing Necrotizing Pancreatitis: Not as Rare as You Think?
Lewellen KA; Maatman TK; Heimberger MA; Ceppa EP; House MG; Nakeeb A; Schmidt CM; Zyromski NJ
J Surg Res; 2020 Jun; 250():53-58. PubMed ID: 32018143
[TBL] [Abstract][Full Text] [Related]
39. United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer.
Oldfield L; Stott M; Hanson R; Jackson RJ; Reynolds W; Chandran-Gorner V; Van Der Meer R; Alison L; Tejeiro R; Purewal T; Ghaneh P; Palmer D; Greenhalf W; Halloran C; Costello E
BMJ Open; 2022 Oct; 12(10):e068010. PubMed ID: 36216424
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics of second primary pancreatic cancer.
Jo JH; Cho IR; Jung JH; Lee HS; Chung MJ; Bang S; Park SW; Chung JB; Song SY; Park JY
PLoS One; 2017; 12(6):e0179784. PubMed ID: 28650984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
